Disclosure statement
No potential conflict of interest was reported by the author(s).
Additional information
Funding
This study was funded by the National Natural Science Foundation of China [contract/grant number: 81873450].
Leukemia & Lymphoma
Volume 61, 2020 - Issue 10
Letters to the Editor
New tricks for old drugs: combination of rituximab and two nanoparticle-delivered chemotherapy drugs, albumin-bound paclitaxel and pegylated liposomal doxorubicin, in the treatment of relapsed/refractory diffuse large B cell lymphoma
Liang WangDepartment of Hematology, Beijing Tongren Hospital, Capital Medical University, Beijing, China; 
http://orcid.org/0000-0002-3995-9097View further author information
http://orcid.org/0000-0002-3995-9097View further author information, & ![Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days]({"type":"image" , "src" : "/sda/5944/TOC-Subject-Sample-2021-Medicine-Dentistry-Nursing-Allied-Health.jpg"})